|
ALG8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.557100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.031800E-02 |
| Normal-vs-Stage2 |
1.768330E-02 |
| Normal-vs-Stage3 |
1.070350E-01 |
| Normal-vs-Stage4 |
2.873700E-02 |
| Stage1-vs-Stage2 |
1.108010E-01 |
| Stage1-vs-Stage3 |
3.276200E-01 |
| Stage1-vs-Stage4 |
3.420400E-02 |
| Stage2-vs-Stage3 |
6.276000E-01 |
| Stage2-vs-Stage4 |
4.388600E-01 |
| Stage3-vs-Stage4 |
2.991800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.981640E-03 |
| Normal-vs-AfricanAmerican |
2.158200E-01 |
| Normal-vs-Asian |
7.920400E-01 |
| Caucasian-vs-AfricanAmerican |
2.386400E-01 |
| Caucasian-vs-Asian |
5.714800E-01 |
| AfricanAmerican-vs-Asian |
8.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.236100E-02 |
| Normal-vs-Female |
1.974920E-04 |
| Male-vs-Female |
6.797800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.555100E-03 |
| Normal-vs-Extreme_Weight |
1.908180E-01 |
| Normal-vs-Obese |
2.706400E-02 |
| Normal-vs-Extreme_Obese |
2.452600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.698400E-02 |
| Normal_Weight-vs-Obese |
4.141000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.308300E-02 |
| Extreme_Weight-vs-Obese |
2.643600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.488200E-02 |
| Obese-vs-Extreme_Obese |
4.260400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.020000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.228200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.762370E-01 |
| Normal-vs-Age(81-100Yrs) |
6.975400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.273000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.831950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.380240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.548470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.566200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.002800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.403550E-02 |
| Normal-VS-Type2 PRCC |
1.470430E-01 |
| Normal-VS-KIRP CIMP |
1.431500E-02 |
| Normal-VS-Unclassified PRCC |
2.582400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.473800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.395400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.035800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.798100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.183400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.192210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.285410E-01 |
| Normal-vs-N1 |
2.746300E-02 |
| Normal-vs-N2 |
1.607540E-02 |
| N0-vs-N1 |
1.444190E-01 |
| N0-vs-N2 |
3.708800E-01 |
| N1-vs-N2 |
9.357200E-01 |
|
|
